Searching across hundreds of databases
Therapeutic strategies should be designed to transform aggressive prostate cancer phenotypes to a chronic situation. To evaluate the effects of the new growth hormone-releasing hormone receptor (GHRH-R) antagonists: MIA-602, MIA-606, and MIA-690 on processes associated with cancer progression as cell proliferation, adhesion, migration, and angiogenesis.
Pubmed ID: 29748961 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets PCNA
View all literature mentionsThis monoclonal targets MMP9
View all literature mentionsThis polyclonal targets Human MMP2
View all literature mentionsThis monoclonal targets Bcl-2 (100)
View all literature mentionsThis monoclonal targets Catenin, beta
View all literature mentionsThis monoclonal targets E-cadherin
View all literature mentionsThe SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
scicrunch.org
